Corcept Presents New Data at ADA: Improved Outcomes in Patients Receiving a GLP-1 with Difficult-to-Control Type 2 Diabetes and Hypercortisolism Treated with Korlym®

anxiety

Corcept Presents New Data at ADA: Improved Outcomes in Patients Receiving a GLP-1 with Difficult-to-Control Type 2 Diabetes and Hypercortisolism Treated with Korlym®

ONLY AVAILABLE IN PAID PLANS.

Originally reported by financialcontent. Read more

Source: https://www.financialcontent.com/article/bizwire-2026-6-6-corcept-presents-new-data-at-ada-improved-outcomes-in-patients-receiving-a-glp-1-with-difficult-to-control-type-2-diabetes-and-hypercortisolism-treated-with-korlym